Literature DB >> 12883239

Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.

Roderick H W Simpson1, Anil R Prasad, Jean E Lewis, Alena Skálová, Leonor David.   

Abstract

Salivary duct carcinoma is a relatively uncommon aggressive neoplasm, typically found in the parotid glands of older men. The histologic appearance is that of an in situ and invasive high-grade adenocarcinoma, and it closely resembles ductal carcinoma of the breast. Several variants of the latter are very well known, but only papillary, sarcomatoid, and low-grade subtypes have so far been reported in salivary duct carcinoma. This study describes the clinicopathologic and immunohistochemical findings in four examples of an additional previously undescribed variant, rich in mucin. Each tumor showed areas of typical salivary duct carcinoma, but in addition there were lakes of epithelial mucin-containing malignant cells, i.e., mucinous (colloid) carcinoma. All four tumors expressed androgen receptors, cytokeratins, epithelial membrane antigen, gross cystic disease fluid protein-15, and carcinoembryonic antigen, but S-100 protein, other myoepithelial markers, and estrogen and progesterone receptors were negative. The mucin antigen profile showed positivity for MUC2, MUC5B, and MUC6 in all cases but only rare staining with MUC5AC and MUC7. Strong immunohistochemical overexpression of HER2/neu was demonstrated in one tumor, together with amplification by fluorescence in situ hybridization; another case was weakly positive with just one antiserum, but the remaining two tumors were completely negative. Small quantities of mucin have often been described in salivary duct carcinoma but not large extracellular mucinous lakes, which though prominent in the present series, were not as extensive as in mucinous adenocarcinoma. The relatively poor clinical outcome of the patients in our study mirrored that seen in usual-type salivary duct carcinoma and emphasizes the importance of differentiating mucin-rich salivary duct carcinoma from pure mucinous (colloid) adenocarcinoma, a tumor not fully defined, but possibly with a better prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883239     DOI: 10.1097/00000478-200308000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  20 in total

Review 1.  Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Authors:  Roderick H W Simpson
Journal:  Head Neck Pathol       Date:  2013-07-03

2.  Salivary duct carcinoma metastatic to eyelid and orbit-a case report.

Authors:  Jignesh G Parikh; Michael A Burnstine; Satoru Kase; Narsing A Rao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-15       Impact factor: 3.117

3.  PD-L1 expression by immunohistochemistry in salivary duct carcinoma.

Authors:  Ameer Hamza; Dianna Roberts; Shirley Su; Randal S Weber; Diana Bell; Renata Ferrarotto
Journal:  Ann Diagn Pathol       Date:  2019-04-03       Impact factor: 2.090

Review 4.  Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment.

Authors:  Masato Nakaguro; Yuichiro Tada; William C Faquin; Peter M Sadow; Lori J Wirth; Toshitaka Nagao
Journal:  Cancer Cytopathol       Date:  2020-05-18       Impact factor: 5.284

Review 5.  [Salivary duct carcinoma].

Authors:  D Hungermann; K Roeser; H Buerger; T Jäkel; T Löning; H Herbst
Journal:  Pathologe       Date:  2005-09       Impact factor: 1.011

Review 6.  Mucin-rich salivary duct carcinoma with signet-ring cell feature ex pleomorphic adenoma of the submandibular gland: a case report of an unusual histology with immunohistochemical analysis and review of the literature.

Authors:  Kimihide Kusafuka; Matsuyoshi Maeda; Masatake Honda; Takashi Nakajima
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

7.  Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.

Authors:  Pierre Saintigny; Yoshitsugu Mitani; Kristen B Pytynia; Renata Ferrarotto; Dianna B Roberts; Randal S Weber; Merrill S Kies; Sankar N Maity; Sue-Hwa Lin; Adel K El-Naggar
Journal:  Cancer       Date:  2018-10-05       Impact factor: 6.860

8.  Malignant transformation of sialadenoma papilliferum of the palate: a case report.

Authors:  Masayuki Shimoda; Kaori Kameyama; Shojiroh Morinaga; Youichi Tanaka; Kazuhiro Hashiguchi; Megumi Shimada; Yasunori Okada
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

Review 9.  Recent advances in the diagnostic pathology of salivary carcinomas.

Authors:  Roderick H W Simpson; Alena Skálová; Silvana Di Palma; Ilmo Leivo
Journal:  Virchows Arch       Date:  2014-08-30       Impact factor: 4.064

Review 10.  [Salivary gland tumors--tumor typing and grading].

Authors:  T Löning; K T Jäkel
Journal:  Pathologe       Date:  2004-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.